Axsome Therapeutics Files 8-K
Ticker: AXSM · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1579428
| Field | Detail |
|---|---|
| Company | Axsome Therapeutics, INC. (AXSM) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: AXSM
TL;DR
AXSM filed a standard 8-K, no major news.
AI Summary
Axsome Therapeutics, Inc. filed an 8-K on June 9, 2025, reporting other events and financial statements. The filing does not contain specific details on new events, financial figures, or material agreements, but serves as a standard regulatory update.
Why It Matters
This filing is a routine regulatory update from Axsome Therapeutics, Inc. and does not appear to contain material new information for investors at this time.
Risk Assessment
Risk Level: low — The filing is a routine 8-K and does not disclose any new material events, risks, or financial information.
Key Players & Entities
- Axsome Therapeutics, Inc. (company) — Registrant
- June 09, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-37635 (identifier) — Commission File Number
- 45-4241907 (identifier) — IRS Employer Identification No.
- One World Trade Center, 29th Floor (address) — Principal Executive Offices
- New York (location) — City of Principal Executive Offices
- 10007 (zip_code) — Zip Code of Principal Executive Offices
- (212) 332-3241 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report for Axsome Therapeutics, Inc., reporting on 'Other Events' and 'Financial Statements and Exhibits' as of June 9, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is June 09, 2025.
Where is Axsome Therapeutics, Inc. incorporated?
Axsome Therapeutics, Inc. is incorporated in Delaware.
What is the Commission File Number for Axsome Therapeutics, Inc.?
The Commission File Number for Axsome Therapeutics, Inc. is 001-37635.
What is the address of Axsome Therapeutics, Inc.'s Principal Executive Offices?
The address of Axsome Therapeutics, Inc.'s Principal Executive Offices is One World Trade Center, 29th Floor, New York, New York, 10007.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Axsome Therapeutics, Inc. (AXSM).